Introducing Stereotactic Radiosurgery to Our Region
Offering the Latest Advance in Cancer Treatment
The Mary Washington Healthcare Regional Cancer Center (RCC) has introduced
stereotactic radiosurgery (SRS) to the Fredericksburg region. RCC is the
only cancer center offering this procedure within a 60-mile radius and
only one of 12 worldwide using this highly advanced level of SRS technology.
SRS is managed by the Regional Cancer Center's experienced physicians
experienced in radiation therapy, neurosurgery, and thoracic surgery.
One of the most recent major medical advances in fighting cancer, SRS has
revolutionized brain and lung cancer treatments. It's unusual for
a regional cancer center to offer such a high level of cancer treatment.
This level of radiation therapy is typically only found in large metropolitan
areas, and academic healthcare centers.
SRS is performed using the Varian TrueBeam™ system, the most advanced
radiation technology. TrueBeam and SRS are offered at the Mary Washington
Hospital Radiation Oncology center located in the new cancer services
building on the Mary Washington Hospital campus.
SRS is a non-surgical procedure for patients who need very precise targeting
when radiation therapy or invasive surgery poses too significant a risk
for damaging surrounding tissue or organs, a complication most often found
in brain and lung cancer. It is also highly effective in treating difficult-to-reach
tumors in the brain and lungs.
Benefits of the new SRS capabilities include:
- Virtual elimination of collateral radiation to healthy surrounding tissue
in vital organs.
- Significant reduction in the risks of traditional neurosurgery and lung
surgery, eliminating long, multiple hour surgeries.
- Elimination of the side effects of invasive surgery.
- Shortened treatment sessions and duration of treatment.
Excellent Physicians Specialize in SRS Treatment
Lead radiation oncology physician,
John C. Chinault, MD, offers a uniquely beneficial advantage: an earlier career as a physicist
compelled him to earn his MD in radiation oncology. He was instrumental
in bringing SRS to the region.
J. Timothy Sherwood, MD, fellowship-trained thoracic surgeon and Associate Professor at Johns
Hopkins University School of Medicine, works with patients on the lung